KDS2010 , a reversible MAO‐B inhibitor, extends the lifetime of neural probes by preventing glial scar formation
Glia · 2024
DOI: 10.1002/glia.24500 ↗Kurz gefasst
Fachartikel in der Zeitschrift Glia, 2024. Verfasst von Uikyu Chae und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Convergence Medicine, College of Medicine, Korea University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Gliosis, Astrocytes. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Ministry of Science and ICT, South Korea, Institute for Basic Science, National Research Foundation of Korea.
Abstract (Originalsprache)
Implantable neural probes have been extensively utilized in the fields of neurocircuitry, systems neuroscience, and brain‐computer interface. However, the long‐term functionality of these devices is hampered by the formation of glial scar and astrogliosis at the surface of electrodes. In this study, we administered KDS2010, a recently developed reversible MAO‐B inhibitor, to mice through ad libitum drinking in order to prevent glial scar formation and astrogliosis. The administration of KDS2010 allowed long‐term recordings of neural signals with implantable devices, which remained stable over a period of 6 months and even restored diminished neural signals after probe implantation. KDS2010 effectively prevented the formation of glial scar, which consists of reactive astrocytes and activated microglia around the implant. Furthermore, it restored neural activity by disinhibiting astrocytic MAO‐B dependent tonic GABA inhibition induced by astrogliosis. We suggest that the use of KDS2010 is a promising approach to prevent glial scar formation around the implant, thereby enabling long‐term functionality of neural devices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Convergence Medicine, College of Medicine, Korea University, Seoul, Republic of Korea.
- Yonsei-SLBigen Research Institute, College of Pharmacy, Yonsei University, Incheon, Republic of Korea.
- Center for Cognition and Sociality, Institute for Basic Science (IBS), Daejeon, Republic of Korea.
- IBS School, University of Science and Technology (UST), Daejeon, Republic of Korea.
- Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea.
- Department of Anatomy, College of Medicine, Korea University, Seoul, Republic of Korea.
ORCID-Profile: Heejung Chun, Jiwoon Lim, C Justin Lee
Förderung
- Ministry of Science and ICT, South Korea
- Institute for Basic Science
- National Research Foundation of Korea
Zitieren
APA
Chae, U., Chun, H., Lim, J., Shin, H., Smith, W. C., Choi, J. W., Park, K. D., Lee, C. J., & Cho, I. J. (2024). KDS2010 , a reversible MAO‐B inhibitor, extends the lifetime of neural probes by preventing glial scar formation. Glia. https://doi.org/10.1002/glia.24500
Vancouver
Chae U, Chun H, Lim J, Shin H, Smith WC, Choi JW, et al. KDS2010 , a reversible MAO‐B inhibitor, extends the lifetime of neural probes by preventing glial scar formation. Glia. 2024. doi:10.1002/glia.24500
BibTeX
@article{Chae2024,
author = {Chae, Uikyu and Chun, Heejung and Lim, Jiwoon and Shin, Hyogeun and Smith, Wesley Charles and Choi, Ji Won and Park, Ki Duk and Lee, C Justin and Cho, Il-Joo},
title = {KDS2010 , a reversible MAO‐B inhibitor, extends the lifetime of neural probes by preventing glial scar formation},
journal = {Glia},
year = {2024},
doi = {10.1002/glia.24500}
}
EUVIMED